Cargando…

Treatment of Digital Ulcers and Reflux Oesophagitis in a Patient with Systemic Sclerosis: Increased Risk of Hepatotoxicity due to a Potential Drug-drug Interaction Between Bosentan and Vonoprazan

Detalles Bibliográficos
Autores principales: KIMURA, Ryoko, SUGITA, Kazunari, SUGIHARA, Takaaki, ISOMOTO, Hajime, YAMAMOTO, Osamu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Society for Publication of Acta Dermato-Venereologica 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9455316/
https://www.ncbi.nlm.nih.gov/pubmed/34694420
http://dx.doi.org/10.2340/actadv.v101.439
_version_ 1784785555839516672
author KIMURA, Ryoko
SUGITA, Kazunari
SUGIHARA, Takaaki
ISOMOTO, Hajime
YAMAMOTO, Osamu
author_facet KIMURA, Ryoko
SUGITA, Kazunari
SUGIHARA, Takaaki
ISOMOTO, Hajime
YAMAMOTO, Osamu
author_sort KIMURA, Ryoko
collection PubMed
description
format Online
Article
Text
id pubmed-9455316
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Society for Publication of Acta Dermato-Venereologica
record_format MEDLINE/PubMed
spelling pubmed-94553162022-10-20 Treatment of Digital Ulcers and Reflux Oesophagitis in a Patient with Systemic Sclerosis: Increased Risk of Hepatotoxicity due to a Potential Drug-drug Interaction Between Bosentan and Vonoprazan KIMURA, Ryoko SUGITA, Kazunari SUGIHARA, Takaaki ISOMOTO, Hajime YAMAMOTO, Osamu Acta Derm Venereol Short Communication Society for Publication of Acta Dermato-Venereologica 2021-11-24 /pmc/articles/PMC9455316/ /pubmed/34694420 http://dx.doi.org/10.2340/actadv.v101.439 Text en © 2021 Acta Dermato-Venereologica https://creativecommons.org/licenses/by-nc/4.0/This is an open access article under the CC BY-NC license
spellingShingle Short Communication
KIMURA, Ryoko
SUGITA, Kazunari
SUGIHARA, Takaaki
ISOMOTO, Hajime
YAMAMOTO, Osamu
Treatment of Digital Ulcers and Reflux Oesophagitis in a Patient with Systemic Sclerosis: Increased Risk of Hepatotoxicity due to a Potential Drug-drug Interaction Between Bosentan and Vonoprazan
title Treatment of Digital Ulcers and Reflux Oesophagitis in a Patient with Systemic Sclerosis: Increased Risk of Hepatotoxicity due to a Potential Drug-drug Interaction Between Bosentan and Vonoprazan
title_full Treatment of Digital Ulcers and Reflux Oesophagitis in a Patient with Systemic Sclerosis: Increased Risk of Hepatotoxicity due to a Potential Drug-drug Interaction Between Bosentan and Vonoprazan
title_fullStr Treatment of Digital Ulcers and Reflux Oesophagitis in a Patient with Systemic Sclerosis: Increased Risk of Hepatotoxicity due to a Potential Drug-drug Interaction Between Bosentan and Vonoprazan
title_full_unstemmed Treatment of Digital Ulcers and Reflux Oesophagitis in a Patient with Systemic Sclerosis: Increased Risk of Hepatotoxicity due to a Potential Drug-drug Interaction Between Bosentan and Vonoprazan
title_short Treatment of Digital Ulcers and Reflux Oesophagitis in a Patient with Systemic Sclerosis: Increased Risk of Hepatotoxicity due to a Potential Drug-drug Interaction Between Bosentan and Vonoprazan
title_sort treatment of digital ulcers and reflux oesophagitis in a patient with systemic sclerosis: increased risk of hepatotoxicity due to a potential drug-drug interaction between bosentan and vonoprazan
topic Short Communication
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9455316/
https://www.ncbi.nlm.nih.gov/pubmed/34694420
http://dx.doi.org/10.2340/actadv.v101.439
work_keys_str_mv AT kimuraryoko treatmentofdigitalulcersandrefluxoesophagitisinapatientwithsystemicsclerosisincreasedriskofhepatotoxicityduetoapotentialdrugdruginteractionbetweenbosentanandvonoprazan
AT sugitakazunari treatmentofdigitalulcersandrefluxoesophagitisinapatientwithsystemicsclerosisincreasedriskofhepatotoxicityduetoapotentialdrugdruginteractionbetweenbosentanandvonoprazan
AT sugiharatakaaki treatmentofdigitalulcersandrefluxoesophagitisinapatientwithsystemicsclerosisincreasedriskofhepatotoxicityduetoapotentialdrugdruginteractionbetweenbosentanandvonoprazan
AT isomotohajime treatmentofdigitalulcersandrefluxoesophagitisinapatientwithsystemicsclerosisincreasedriskofhepatotoxicityduetoapotentialdrugdruginteractionbetweenbosentanandvonoprazan
AT yamamotoosamu treatmentofdigitalulcersandrefluxoesophagitisinapatientwithsystemicsclerosisincreasedriskofhepatotoxicityduetoapotentialdrugdruginteractionbetweenbosentanandvonoprazan